Special Issue "Probiotics and Prebiotics"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 March 2012)
Prof. Dr. Yasuhiro Koga
Laboratory for Infectious Diseases, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
Interests: probiotics; prebiotics; bifidobacteria; gnotobiology; helicobacter pylori; stomach; atopic dermatitis; gut-brain axis
Probiotics are defined as live non-pathogenic bacteria that beneficially affect the host by influencing the microbiota of the digestive tract. Prebiotics, that are usually saccharides and fiber, represent a source of energy being metabolized by the intestinal and probiotic microbiota. In the last several decades, a rapid enlargement in the use of probiotics/prebiotics occurred for prevention and treatment of diseases in medicine, such as diarrhea caused by certain pathogenic bacteria and viruses, Helicobacter pylori infection, and allergy etc. Rigid evidence supporting the efficacy of probiotics/prebiotics in such clinical uses and mechanical studies are now needed in order to firmly establish them in the modern medicine.
Prof. Dr. Yasuhiro Koga
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- prevention of diarrhea caused by pathogenic bacteria and viruses
- Helicobacter pylori infection and complications
- inflammatory bowel diseases
- irritable bowel syndrome
- mucosal immunity
- gut-brain axis
Article: Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization
Pharmaceuticals 2012, 5(2), 236-248; doi:10.3390/ph5020236
Received: 23 December 2011; in revised form: 3 February 2012 / Accepted: 10 February 2012 / Published: 16 February 2012| Download PDF Full-text (726 KB) | Download XML Full-text
Article: Biochemical Traits, Survival and Biological Properties of the Probiotic Lactobacillus plantarum Grown in the Presence of Prebiotic Inulin and Pectin as Energy Source
Pharmaceuticals 2012, 5(5), 481-492; doi:10.3390/ph5050481
Received: 11 April 2012; in revised form: 9 May 2012 / Accepted: 11 May 2012 / Published: 15 May 2012| Download PDF Full-text (228 KB) | Download XML Full-text
Pharmaceuticals 2012, 5(6), 629-642; doi:10.3390/ph5060629
Received: 1 April 2012; in revised form: 29 May 2012 / Accepted: 5 June 2012 / Published: 18 June 2012| Download PDF Full-text (73 KB) | Download XML Full-text
Pharmaceuticals 2012, 5(6), 655-664; doi:10.3390/ph5060655
Received: 16 May 2012; in revised form: 4 June 2012 / Accepted: 6 June 2012 / Published: 19 June 2012| Download PDF Full-text (570 KB) | Download XML Full-text
Pharmaceuticals 2012, 5(6), 665-673; doi:10.3390/ph5060665
Received: 7 May 2012; in revised form: 13 June 2012 / Accepted: 15 June 2012 / Published: 19 June 2012| Download PDF Full-text (205 KB) | Download XML Full-text
Pharmaceuticals 2012, 5(7), 727-744; doi:10.3390/ph5070727
Received: 12 April 2012; in revised form: 26 June 2012 / Accepted: 29 June 2012 / Published: 6 July 2012| Download PDF Full-text (181 KB) | Download XML Full-text
Last update: 20 June 2012